Polymyositis during pegylated alpha-interferon ribavirin therapy for chronic hepatitis

Indian J Gastroenterol. 2007 May-Jun;26(3):147-8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Female
  • Hepatitis C, Chronic / complications
  • Hepatitis C, Chronic / diet therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage
  • Interferon-alpha / adverse effects*
  • Middle Aged
  • Polyethylene Glycols / administration & dosage
  • Polyethylene Glycols / adverse effects*
  • Polymyositis / chemically induced*
  • Recombinant Proteins
  • Ribavirin / administration & dosage*

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2a